Consistently, the protein and mRNA detection showed that the RanBP3 levels in CML cells (BCR-ABL+) were much higher than that of other leukemia cells (BCR-ABL-) (Figures 1C, D). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.